title: Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning.
abstract: This article describes an electrospinning process to fabricate double-layered ultrafine fibers. A bioabsorbable polymer, Polycaprolactone (PCL), was used as the outer layer or the shell and two medically pure drugs, Resveratrol (RT, a kind of antioxidant) and Gentamycin Sulfate (GS, an antibiotic), were used as the inner layers or the cores. Morphology and microstructure of the ultrafine fibers were characterized by scanning electron microscope (SEM) and transmission electron microscopy (TEM), whereas mechanical performance of them was understood through tensile test. In vitro degradation rates of the nanofibrous membranes were determined by measuring their weight loss when immersed in pH 7.4 phosphate-buffered saline (PBS) mixed with certain amount of Pseudomonas lipase for a maximum of 7 days. The drug release behaviors of the RT and GS were measured using a high performance liquid chromatography (HPLC) and ultraviolet-visible (UV-vis) spectroscopy, respectively. It has been found that the drug solutions without any fiber-forming additive could be encapsulated in the PCL ultrafine fibers, although they alone cannot be made into a fiber form. Beads on the fiber surface influenced the tensile behavior of the ultrafine fibers remarkably. When the core solvent was miscible with the shell solvent, higher drug concentration decreased the bead formation and thus favored the mechanical performance. The situation, however, became different if the two solvents were immiscible with each other. The degradation rate was closely related to hydrophilicity of the drugs in the cores. Higher hydrophilicity apparently led to faster degradation. The release profiles of the RT and GS exhibited a sustained release characteristic, with no burst release phenomenon.
authors.affiliation: School of Aerospace Engineering and Applied Mechanics, Tongji University, Shanghai 200092, People's Republic of China. huangzm@mail.tongji.edu.cn
authors.forename: Zheng-Ming
authors.initials: ZM
authors.lastname: Huang
authors.forename: Chuang-Long
authors.initials: CL
authors.lastname: He
authors.forename: Aizhao
authors.initials: A
authors.lastname: Yang
authors.forename: Yanzhong
authors.initials: Y
authors.lastname: Zhang
authors.forename: Xiao-Jian
authors.initials: XJ
authors.lastname: Han
authors.forename: Junlin
authors.initials: J
authors.lastname: Yin
authors.forename: Qingsheng
authors.initials: Q
authors.lastname: Wu
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D000975:Antioxidants / Q000008:administration & dosage / Q000493:pharmacokinetics; D001672:Biocompatible Materials / Q000737:chemistry; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D016503:Drug Delivery Systems; D004563:Electrochemistry / Q000295:instrumentation / Q000379:methods; D005839:Gentamicins / Q000008:administration & dosage / Q000493:pharmacokinetics; D008422:Materials Testing; D008854:Microscopy, Electron; D049329:Nanostructures; D011091:Polyesters / Q000737:chemistry; D000077185:Resveratrol; D013267:Stilbenes / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000900:Anti-Bacterial Agents; D000975:Antioxidants; D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D005839:Gentamicins; D011091:Polyesters; D013267:Stilbenes; C016240:polycaprolactone; D000077185:Resveratrol